Home Cart 0 Sign in  

[ CAS No. 17857-14-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 17857-14-6
Chemical Structure| 17857-14-6
Structure of 17857-14-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17857-14-6 ]

Related Doc. of [ 17857-14-6 ]

Alternatived Products of [ 17857-14-6 ]

Product Details of [ 17857-14-6 ]

CAS No. :17857-14-6 MDL No. :MFCD00274196
Formula : C22H22BrO2P Boiling Point : -
Linear Structure Formula :- InChI Key :NKVJKVMGJABKHV-UHFFFAOYSA-N
M.W : 429.29 Pubchem ID :10717451
Synonyms :

Calculated chemistry of [ 17857-14-6 ]

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.14
Num. rotatable bonds : 7
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 116.13
TPSA : 50.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : -1.59
Log Po/w (XLOGP3) : 5.45
Log Po/w (WLOGP) : 0.85
Log Po/w (MLOGP) : 5.13
Log Po/w (SILICOS-IT) : 4.77
Consensus Log Po/w : 2.92

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -5.99
Solubility : 0.000444 mg/ml ; 0.00000103 mol/l
Class : Moderately soluble
Log S (Ali) : -6.28
Solubility : 0.000228 mg/ml ; 0.00000053 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.09
Solubility : 0.00000346 mg/ml ; 0.0000000081 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.48

Safety of [ 17857-14-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 17857-14-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17857-14-6 ]
  • Downstream synthetic route of [ 17857-14-6 ]

[ 17857-14-6 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 2623-87-2 ]
  • [ 603-35-0 ]
  • [ 17857-14-6 ]
YieldReaction ConditionsOperation in experiment
92% for 48 h; Inert atmosphere; Reflux General procedure: A mixture of ω-bromocarboxylic acid (1 equiv) and triphenylphosphine (1 equiv) in 300 mL of toluene was refluxed for 48 h under argon. The mixture was allowed to cool at room temperature and concentrated in vacuum. The residue was crystallized from various solvents to give the corresponding phosphonium salt.
89% at 120℃; for 16 h; Inert atmosphere General procedure: Triphenylphosphine (3.76g, 14.34mmol) and ethyl 4-bromobutyrate (2.0g, 10.25mmol) were added to a dried round bottom flask under argon. The reaction mixture was heated to 120°C under condenser for 16h after which the reaction was allowed to come to room temperature. CH2Cl2 (10mL) was added, followed by diethyl ether until no further precipitation of product was observed. The precipitate was further washed with ether (100mL) and dried in vacuo to give pure compound 2 as a white solid (4.64g) in quantitative yield.
74% for 15 h; Reflux; Inert atmosphere Compound 14 was synthesized according to the method of Yeung.1 To a flame-dried 50 mL flask under argon equipped with a magnetic stirring bar was added a solution of γ-bromoacid 13 (2.50 g, 14.9 mmol, 1.00 eq.) in 20 mL of anhydrous acetonitrile. Solid triphenylphosphine (3.94 g, 14.9 mmol, 1.00 eq.) was added, the flask was equipped with a water-cooled condenser, and the reaction mixture was heated to reflux. Upon heating, all of the triphenylphosphine gradually dissolved to give an almost colorless solution; after 20 minutes, a white precipitate of the phosphonium started to form. After heating at reflux for 15 hours, the reaction mixture was allowed to cool slowly to room temperature. The precipitate was collected by vacuum filtration, washed with two 5 mL portions of cold acetonitrile, and dried under high vacuum to give pure phosphonium salt 14 (3.03 g, 47percent) as a fine white solid [mp 245–247.5 °C]. Evaporation of the filtrate afforded a yellow/orange solid that was triturated with a minimum amount of cold acetonitrile to give an additional 1.72 g (27percent) of 14 as a pale yellow powder.
64.2% at 105℃; for 48 h; Experimental procedure: Take a 250mL single-mouth round bottom flask,4-bromobutyric acid 1 (15.0 g, 1.0 eq) was added in succession.MeCN (120.0 mL) and triphenylphosphine (23.6 g, 1.0 eq).Heat to reflux, reflux temperature 105 °C,The reaction solution was a yellow liquid and reacted for about 2 days.Post-reaction treatment: The reaction system was directly filtered with a fritted funnel, washed with diethyl ether, and then vacuum-dried to obtain a white solid with a yield of 64.2percent.

Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 1, p. 567 - 579
[2] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 21, p. 5088 - 5102
[3] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2002, vol. 57, # 3, p. 335 - 337
[4] Tetrahedron Letters, 2016, vol. 57, # 10, p. 1083 - 1086
[5] Journal of the American Chemical Society, 2018, vol. 140, # 17, p. 5805 - 5813
[6] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5878 - 5881
[7] Patent: CN106946700, 2017, A, . Location in patent: Paragraph 0030; 0031; 0032
[8] Organic Letters, 2016, vol. 18, # 10, p. 2395 - 2398
[9] Journal of Organic Chemistry, 1989, vol. 54, # 17, p. 4224 - 4228
[10] Chemische Berichte, 1977, vol. 110, p. 3544 - 3552
[11] Journal of Organic Chemistry, 1991, vol. 56, # 13, p. 4196 - 4204
[12] Journal of Medicinal Chemistry, 1985, vol. 28, # 3, p. 287 - 294
[13] Journal of Medicinal Chemistry, 2008, vol. 51, # 12, p. 3487 - 3498
[14] Patent: US6753449, 2004, B2, . Location in patent: Page column 15
[15] Organic Letters, 2011, vol. 13, # 10, p. 2738 - 2741
[16] Angewandte Chemie - International Edition, 2012, vol. 51, # 9, p. 2187 - 2190
[17] Journal of Organic Chemistry, 2013, vol. 78, # 5, p. 1718 - 1729
[18] Applied Catalysis A: General, 2014, vol. 470, p. 183 - 188
[19] Organic Letters, 2016, vol. 18, # 3, p. 504 - 507
[20] Organic Letters, 2017, vol. 19, # 18, p. 4940 - 4943
[21] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 275 - 284
[22] Patent: WO2018/106928, 2018, A1, . Location in patent: Page/Page column 29; 32
  • 2
  • [ 96-48-0 ]
  • [ 6399-81-1 ]
  • [ 17857-14-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1997, vol. 45, # 4, p. 685 - 696
[2] Justus Liebigs Annalen der Chemie, 1967, vol. 709, p. 105 - 112
Same Skeleton Products
Historical Records